JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

Search

Revvity Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

97.11 -1.84

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

92.16

Max

97.95

Pagrindiniai rodikliai

By Trading Economics

Pajamos

14M

55M

Pardavimai

56M

720M

P/E

Sektoriaus vid.

41.439

37.461

Pelnas, tenkantis vienai akcijai

1.18

Dividendų pajamingumas

0.3

Pelno marža

7.667

Darbuotojai

11,000

EBITDA

22M

194M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+11.23% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.30%

2.33%

Kitas uždarbis

2025-10-27

Kitas dividendų mokėjimo data

2025-11-07

Kita Ex Dividend data

2026-01-16

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

370M

11B

Ankstesnė atidarymo kaina

98.95

Ankstesnė uždarymo kaina

97.11

Naujienos nuotaikos

By Acuity

35%

65%

93 / 373 reitingas Healthcare

Revvity Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-26 23:52; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-26 23:52; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen -- Market Talk

2025-10-26 23:46; UTC

Rinkos pokalbiai

Oil Rises Amid Ongoing Supply Concerns -- Market Talk

2025-10-26 23:41; UTC

Rinkos pokalbiai

Gold Falls; U.S.-China Trade Deal Optimism Overcomes Signs of Cooler U.S. Inflation -- Market Talk

2025-10-26 23:34; UTC

Uždarbis

Sinopharm Group 9-Mos Oper Pft CNY10.87B Vs. Pft CNY10.84B >1099.HK

2025-10-26 23:32; UTC

Uždarbis

Sinopharm Group 9-Mos Net CNY5.31B Vs. Net CNY5.28B >1099.HK

2025-10-26 23:30; UTC

Uždarbis

Sinopharm Group 9-Mos Rev CNY431.48B Vs. CNY442.42B >1099.HK

2025-10-26 22:29; UTC

Uždarbis

WuXi AppTec 3Q Rev CNY12.06B ; up 15.3% on Year>603259.SH

2025-10-26 22:29; UTC

Uždarbis

WuXi AppTec: Higher Contributions From Contract Research Development and Manufacturing Organization Unit Supported Results>603259.SH

2025-10-26 22:29; UTC

Uždarbis

WuXi AppTec: Results Also Boosted From Divestment Gains >603259.SH

2025-10-26 22:29; UTC

Uždarbis

WuXi AppTec 3Q Net CNY5.13B ; up 82.9% on Year>603259.SH

2025-10-26 22:16; UTC

Uždarbis

Stock Futures Rise Ahead of Mag 7 Earnings, Fed Decision -- Barrons.com

2025-10-26 21:33; UTC

Įsigijimai, susijungimai, perėmimai

Novartis Agrees to Acquire Avidity Biosciences for $12 Billion -- WSJ

2025-10-26 19:29; UTC

Įsigijimai, susijungimai, perėmimai

Novartis Deal Values Avidity Biosciences At $12 Billion -- Barrons.com

2025-10-26 06:39; UTC

Uždarbis

CITIC Securities 3Q Rev CNY22.78B Vs. CNY15.96B >6030.HK

2025-10-26 06:39; UTC

Uždarbis

CITIC Securities: Higher Income From Brokerage, Investment Banking Supported Results>6030.HK

2025-10-26 06:39; UTC

Uždarbis

CITIC Securities 3Q Net CNY9.44B Vs. Net CNY6.23B >6030.HK

2025-10-24 21:24; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-24 21:24; UTC

Rinkos pokalbiai

Moody's Sees France With Increased Risk of Political Dysfunction -- Market Talk

2025-10-24 21:07; UTC

Uždarbis

The Score: Netflix, Amazon.com, Six Flags and More Stocks That Defined the Week -- WSJ

2025-10-24 20:58; UTC

Uždarbis

S&P 500 Climbs to New Record on Strong Earnings -- WSJ

2025-10-24 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-10-24 20:40; UTC

Uždarbis

Intel Expects Chip Shortages on Better PC Demand. Here's Why AMD Is Winning Too. -- Barrons.com

2025-10-24 20:24; UTC

Uždarbis

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

2025-10-24 20:23; UTC

Uždarbis

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

2025-10-24 20:13; UTC

Uždarbis

These Stocks Moved the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

2025-10-24 20:07; UTC

Rinkos pokalbiai

Different-Cell Imputation Rose Proportionally in September CPI -- Market Talk

2025-10-24 19:40; UTC

Rinkos pokalbiai

Treasury Yields Mixed, Dollar Stronger Ahead of Fed Week -- Market Talk

2025-10-24 19:35; UTC

Rinkos pokalbiai

Oil Rally on U.S. Russia Sanctions Loses Steam -- Market Talk

2025-10-24 19:33; UTC

Uždarbis

IBM and Google Are Also Making Moves in Quantum. Don't Count Out the Bigger Players. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Revvity Inc Prognozė

Kainos tikslas

By TipRanks

11.23% į viršų

12 mėnesių prognozė

Vidutinis 110 USD  11.23%

Aukščiausias 126 USD

Žemiausias 99 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Revvity Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

14 ratings

8

Pirkti

6

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

93 / 373 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat